Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,165 USD | -1,58 % | -0,57 % | +4,00 % |
18/03 | Fulcrum Therapeutics nombra a Patrick Horn director médico | MT |
18/03 | Fulcrum Therapeutics, Inc. anuncia cambios ejecutivos | CI |
Resumen de negocios
Número de empleados: 76
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alex Sapir
CEO | Chief Executive Officer | 57 | 01/07/23 |
Alan Musso
DFI | Director of Finance/CFO | 61 | 07/08/23 |
Chief Tech/Sci/R&D Officer | - | 01/07/21 | |
Leslie Leinwand
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 01/12/22 | |
Robert Gould
BRD | Director/Board Member | 69 | - |
Iain Fraser
PRN | Corporate Officer/Principal | - | 01/03/23 |
Kristina Storey
LAW | General Counsel | - | 01/11/22 |
Paul Bruno
PRN | Corporate Officer/Principal | - | 01/01/19 |
Comptroller/Controller/Auditor | - | 11/03/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 70 | 19/07/16 |
Director/Board Member | 70 | 01/12/16 | |
James Collins
BRD | Director/Board Member | 58 | 01/01/17 |
Robert Gould
BRD | Director/Board Member | 69 | - |
Kathryn Haviland
CHM | Chairman | 48 | 27/06/18 |
Katina Dorton
BRD | Director/Board Member | 66 | 02/01/20 |
Alex Sapir
CEO | Chief Executive Officer | 57 | 01/07/23 |
Sonja L. Banks
BRD | Director/Board Member | 55 | 08/12/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 62 153 638 | 61 297 958 ( 98,62 %) | 0 | 98,62 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,00 % | 452 M | |
+1,20 % | 43,84 mil M | |
+5,29 % | 41,68 mil M | |
+44,76 % | 41,25 mil M | |
-10,92 % | 27,04 mil M | |
+8,51 % | 25,53 mil M | |
-25,55 % | 18,18 mil M | |
-2,63 % | 12,29 mil M | |
+25,85 % | 12,29 mil M | |
+7,05 % | 11,15 mil M |
- Bolsa de valores
- Acciones
- Acción FULC
- Empresa Fulcrum Therapeutics, Inc.